
Appeals Board ruling puts Centriq–Dis-Chem partnership on the line
In Circular 48, the CMS signals tougher enforcement against exempted insurers, warning that non-compliant branding and failure to notify regulators will attract decisive action.

In Circular 48, the CMS signals tougher enforcement against exempted insurers, warning that non-compliant branding and failure to notify regulators will attract decisive action.

The acquisition is in line with the group’s strategy to develop a portfolio of health-centric financial services products.

Dis-Chem is in the clear. TransUnion was issued with an Enforcement Notice, and the Information Regulator is investigating the data breach at the CIPC.